Top Markets
#1 Black Phoenix Black Phoenix +21,378.52%
#2 Nesa Nesa +678.85%
#3 Cortex Cortex +91.99%
#4 Ontology Gas Ontology Gas +65.81%
#5 Kinesis Silver Kinesis Silver +53.75%
#6 Magma Finance Magma Finance +26.35%
#7 Biconomy Biconomy +25.07%
#8 QuantixAI QuantixAI +23.07%
#9 EXOD EXOD +22.78%
#10 SAFEcoin SAFEcoin +20.23%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Rangering i aksjer #19056
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Aksjekurs
$1.27
Markedsverdi
$176.31M
Endring (1 dag)
5.57%
Endring (1 år)
29.36%
Land
TW
Handel Medigen Biotechnology Corp. (3176)

Kategori

Healthcare
Inntekter for Medigen Biotechnology Corp. (3176)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Medigen Biotechnology Corp. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Medigen Biotechnology Corp. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH